Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. (Q54268700)

16 June 2018

title

Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. (English)

1 reference

16 June 2018

0 references

1 reference

8

Lorenz von Seidlein

1 reference

16 June 2018

13

Jan Holmgren

1 reference

16 June 2018

14

John Clemens

1 reference

16 June 2018

Anna Lena Lopez

3

Anna Lena Lopez

1 reference

16 June 2018

Rodney Carbis

9

Rodney Carbis

1 reference

16 June 2018

Stephen Attridge

12

Stephen Attridge

1 reference

16 June 2018

Jiebin Zhang

2

Do Gia Canh

1 reference

16 June 2018

Duc Anh Dang

1

Dang Duc Anh

1 reference

16 June 2018

author name string

Vu Dinh Thiem

4

1 reference

16 June 2018

Phan Thi Long

5

1 reference

16 June 2018

Nguyen Hong Son

6

1 reference

16 June 2018

Jacqueline Deen

7

1 reference

16 June 2018

Seung Hyun Han

10

1 reference

16 June 2018

Seong Hye Shin

11

1 reference

16 June 2018

language of work or name

English

0 references

publication date

29 September 2006

1 reference

16 June 2018

published in

Vaccine

1 reference

16 June 2018

volume

25

1 reference

16 June 2018

page(s)

1149-1155

1 reference

16 June 2018

issue

6

1 reference

16 June 2018

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.049

Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.049

Significance Testing to Establish Equivalence between Treatments, with Special Reference to Data in the Form of 2 x 2 Tables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.049

Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.049

Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.049

B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.049

Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.049

Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.049

Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.049

Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.049

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.09.049

1 reference

16 June 2018

PubMed ID

17055622

1 reference

16 June 2018